SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud V...
November 14 2016 - 11:37AM
Business Wire
Levi & Korsinsky announces it has commenced an investigation
of Dynavax Technologies Corporation (“Dynavax” or the “Company”)
(NASDAQ: DVAX) concerning possible violations of federal securities
laws by certain officers and directors.
On November 14, 2016, Dynavax fell more than 62% on intraday
trading following an announcement that the Company had received a
Complete Response Letter from the U.S. Food and Drug
Administration. According to Dynavax, the CRL requests further
information on several topics “including clarification regarding
specific adverse events of special interest (AESIs), a numerical
imbalance in a small number of cardiac events in a single study
(HBV-23), new analyses of the integrated safety data base across
different time periods, and post-marketing commitments.” To obtain
additional information about the investigation, go to:
http://zlk.9nl.com/dynavax
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161114006126/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq.30 Broad Street -
24th FloorNew York, NY 10004Tel: 212-363-7500Toll Free:
877-363-5972Fax: 212-363-7171www.zlk.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024